 BOSTON, April 08, 2022 GLOBE NEWSWIRE -- X4 Pharmaceuticals, Inc. Nasdaq: XFOR, a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit people with diseases of the immune system, today announced that it will present a poster on its Waldenströms macroglobulinemia program at the upcoming American Association for Cancer Research AACR Annual Meeting 2022 to be held in New Orleans, LA April 8-12, 2022. 